{"nct_id":"NCT01974895","title":"Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2013-10-23","start_date_type":null,"primary_completion_date":"2014-02-27","primary_completion_date_type":"ACTUAL","completion_date":"2014-07-03","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}